True Wealth Design LLC lifted its holdings in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 16,600.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 167 shares of the medical technology company’s stock after buying an additional 166 shares during the quarter. True Wealth Design LLC’s holdings in Teleflex were worth $41,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently bought and sold shares of TFX. Cromwell Holdings LLC lifted its position in shares of Teleflex by 59.0% during the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after acquiring an additional 49 shares in the last quarter. Avior Wealth Management LLC raised its stake in shares of Teleflex by 190.6% during the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after purchasing an additional 101 shares during the period. Ashton Thomas Securities LLC bought a new position in Teleflex in the 3rd quarter worth about $40,000. GAMMA Investing LLC boosted its stake in Teleflex by 131.1% in the 3rd quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock worth $42,000 after purchasing an additional 97 shares during the period. Finally, Canada Pension Plan Investment Board purchased a new position in Teleflex during the 2nd quarter valued at about $42,000. 95.62% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts have recently commented on the stock. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday. Truist Financial reissued a “hold” rating and issued a $227.00 price target (down from $255.00) on shares of Teleflex in a report on Monday, November 4th. Mizuho decreased their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Royal Bank of Canada dropped their price objective on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Finally, Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Friday, November 1st. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $259.25.
Teleflex Stock Up 0.4 %
TFX opened at $192.85 on Monday. The business’s fifty day simple moving average is $219.90 and its 200 day simple moving average is $222.43. Teleflex Incorporated has a 52 week low of $185.66 and a 52 week high of $257.85. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The stock has a market cap of $8.96 billion, a PE ratio of 38.34, a P/E/G ratio of 1.97 and a beta of 1.18.
Teleflex (NYSE:TFX – Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, beating the consensus estimate of $3.38 by $0.11. The firm had revenue of $764.40 million for the quarter, compared to analyst estimates of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company’s revenue was up 2.4% on a year-over-year basis. During the same period in the prior year, the company earned $3.64 EPS. As a group, research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.
Teleflex Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.71%. Teleflex’s payout ratio is 27.04%.
About Teleflex
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Stories
- Five stocks we like better than Teleflex
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- What is an Earnings Surprise?
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- 5 Top Rated Dividend Stocks to Consider
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.